Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT
· Real-Time Price · USD
26.67
0.22 (0.83%)
At close: Aug 15, 2025, 3:59 PM
26.50
-0.64%
After-hours: Aug 15, 2025, 07:37 PM EDT
Summit Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | -235K | -235K | n/a | n/a | 235.71K | 455.7K | 455.7K | 705.71K | 956K | 2.04M | 1.87M | 1.81M | 1.74M | 615K | 728K |
Cost of Revenue | 14.98M | 15M | 15.01M | 672K | 1.25M | 1.7M | 1.68M | 1.67M | 1.07M | 637.95K | 637.95K | 41.95K | 41.95K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -14.98M | -15M | -15.01M | -907K | -1.49M | -1.7M | -1.68M | -1.43M | -611K | -181.95K | 68.05K | 914.05K | 2M | 1.87M | 1.81M | 1.74M | 615K | 728K |
Operating Income | -190.58M | -250.2M | -225.73M | -188.52M | -150.9M | -107.08M | -601.84M | -593.74M | -590.19M | -587.09M | -72.09M | -77.84M | -80.38M | -91.42M | -86.19M | -73.69M | -71.14M | -59.81M |
Interest Income | 17.33M | 17.33M | 13.47M | 2.38M | 4.86M | 8.15M | 8.15M | 5.77M | 3.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -746.05M | -240.73M | -221.29M | -196.68M | -161.69M | -116.03M | -614.93M | -597.59M | -595.47M | -594.53M | -73.55M | -74.36M | -74.81M | -78.69M | -69.97M | -63.5M | -61.7M | -56.53M |
Net Income | -746.08M | -240.75M | -221.31M | -188.8M | -153.81M | -108.14M | -607.04M | -597.59M | -597.71M | -599.76M | -78.78M | -85.29M | -83.5M | -91.15M | -87.24M | -75.11M | -73.22M | -64.03M |
Selling & General & Admin | 410.8M | 64.34M | 60.27M | 57.47M | 42.51M | 34.88M | 30.3M | 26.23M | 26.36M | 26.98M | 26.7M | 26.95M | 27.03M | 26.09M | 23.61M | 19.67M | 21.47M | 20.78M |
Research & Development | 348.41M | 171.19M | 150.79M | 118.86M | 96.46M | 75.11M | 54.12M | 40.04M | 41.77M | 41.33M | 52M | 69.72M | 72.61M | 80.9M | 75.05M | 61.49M | 52.19M | 46.37M |
Other Expenses | 68K | 14.92M | 14.92M | 15.01M | 14.68M | -141K | 520.19M | 527.67M | 522.85M | 520.34M | -3.65M | -12.08M | -7.3M | -5.51M | -5.8M | -6.65M | -7.43M | -6.86M |
Operating Expenses | 759.28M | 250.46M | 226M | 196.63M | 159.01M | 115.19M | 609.95M | 594M | 590.41M | 587.54M | 72.79M | 78.79M | 82.43M | 93.29M | 88M | 75.43M | 71.76M | 63.51M |
Interest Expense | 2.46M | 5.57M | 8.69M | 11.57M | 11.84M | 11.26M | 16.46M | 16.47M | 14.44M | 12.58M | 4.4M | 2.55M | 1.97M | 1.53M | 1.95M | 894K | 781K | 620K |
Selling & Marketing Expenses | n/a | -20K | -20K | -20K | -20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 190.58M | 250.2M | 225.73M | 196.37M | 155.05M | 111.22M | 605.99M | 586.54M | 586.9M | 584.03M | 69.29M | 78.79M | 82.43M | 93.29M | 88M | 75.43M | 71.76M | 63.51M |
Income Tax Expense | 264K | 105K | 105K | 2.9M | 2.04M | 2.19M | 2.19M | -3.5M | 1.54M | 2.18M | 1.42M | 5.38M | 1.04M | 1.09M | 2.42M | 1.24M | 1.03M | 155K |
Shares Outstanding (Basic) | 742.62M | 738.08M | 737.5M | 703.17M | 670.94M | 701.78M | 701.66M | 697.74M | 697.68M | 378.16M | 211.09M | 148.58M | 99.65M | 98.07M | 96.72M | 97.45M | 90.65M | 82.82M |
Shares Outstanding (Diluted) | 742.62M | 738.08M | 737.5M | 726.66M | 707.9M | 701.78M | 701.66M | 697.74M | 697.68M | 378.16M | 211.09M | 148.58M | 99.65M | 98.07M | 96.78M | 98.97M | 92.07M | 82.82M |
EPS (Basic) | -1.01 | -0.33 | -0.31 | -0.28 | -0.23 | -0.17 | -1.53 | -1.56 | -1.63 | -1.73 | -0.45 | -0.65 | -0.75 | -0.9 | -0.96 | -0.86 | -0.92 | -0.88 |
EPS (Diluted) | -1.01 | -0.33 | -0.31 | -0.28 | -0.23 | -0.17 | -1.53 | -1.56 | -1.63 | -1.73 | -0.45 | -0.65 | -0.75 | -0.9 | -0.96 | -0.86 | -0.92 | -0.88 |
EBITDA | -177.55M | -234.81M | -212.25M | -184.17M | -149.17M | -104.06M | -597.69M | -580.36M | -581.83M | -585.2M | -71.87M | -83.65M | -82.64M | -90.64M | -86.45M | -72.15M | -68.8M | -60.19M |
EBIT | -177.88M | -235.16M | -212.6M | -185.1M | -149.85M | -104.77M | -598.47M | -581.12M | -583.27M | -587.18M | -74.38M | -86.24M | -85.14M | -93.23M | -88.9M | -74.59M | -71.08M | -62.23M |
Depreciation & Amortization | -22K | -2K | n/a | 672K | 684K | 710K | 773K | 764K | 1.44M | 1.99M | 2.51M | 2.59M | 2.51M | 2.58M | 2.46M | 2.44M | 2.27M | 2.04M |